Blog | HemaCare

B Cells from Multiple Sclerosis Patients Promote T Helper Cell Responses to Neuro-antigens

Apr 28, 2017 9:00:35 AM / by Stacy Matthews Branch, DVM, PhD posted in cells, Cytotoxic T Cells, disease, primary, Basic Research

0 Comments

Multiple sclerosis (MS) is an autoimmune disease that may develop with the help of B cells. One piece of evidence that suggests this is the ability of B cell depletion therapy to reduce MS-related CNS inflammation. Since T helper cells (especially Th17) are believed to mediate MS development, studies that determine how B cells influence T helper cells are important in understanding MS pathogenesis.

Read More

Comparisons between Primary NK, Engineered NK-92, and Jurkat T Cells Demonstrate Their Importance in Antibody Drug Development

Apr 27, 2017 9:00:59 AM / by Stacy Matthews Branch, DVM, PhD posted in bioresearch, cells, Cytotoxic T Cells, disease, primary, Basic Research

0 Comments

Antibody-based drugs are developed as an immunotherapeutic approach to treat different types of cancer. An important step in the antibody drug–development process is the use of antibody-dependent cell-mediated cytotoxicity (ADCC) assays due to this mechanism of action for most antibody drugs. These assays require the use of effector cells, and those used most often are natural killer (NK) cells obtained from human donors and engineered cells (NK-92 and Jurkate T cells).

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts